We offer a large selection of prebuilt CRISPR knock-in cell lines within the RAS-RAF pathway utilizing the HiBiT tag. Cell backgrounds including LgBiT allow live-cell kinetic analysis of the HiBiT-tagged protein.

Search list for your cell line of interest (e.g., KRAS(WT), RAF1)
Buscar Filter By
KI Cell Line Background
HiBiT-KRAS(G12C) MIA PaCa-2
HiBiT-KRAS(G12D) AsPc-1
HiBiT-KRAS(G12D) SW1990
HiBiT-KRAS(G12D) HEK293
HiBiT-KRAS(G12S) A549
HiBiT-KRAS(G12V) HEK293
HiBiT-KRAS(G12V) SW620
HiBiT-KRAS(G13D) NCI-H647
HiBiT-KRAS(WT) HEK293
HiBiT-KRAS(WT) NCl-H1299
HiBiT-NRAS(Q61R) SW1271
HiBiT-NRAS(WT) HEK293
HiBiT-ARAF A549
HiBiT-BRAF A549
HiBiT-BRAF(V600E) A375
RAF1-HiBiT A549
RAF1-HiBiT Hs766T
RAF1-HiBiT PANC 08.13

Would you like an offline copy of a table listing all CRISPR-tagged cell lines?

Download PDF

Ordering Options

Contact us to get started with the cell lines you need or to stay updated on our growing list of available knock-in cell lines.

If you do not see a form below, please turn off your ad blocker and refresh the page.

CRISPR Ready-to-Use Knock-in Reporter Cells - Inquiry
First Name*
 
 
 
 
Last Name*
 
 
 
 
Company/Institute*
 
 
 
 
State/Region*
 
 
 
 
Country - Full List*
 
 
 
 
Email*
 
 
 
 
Phone*
 
 
 
 
 
 
 
Communication Method*
 
Email
Phone
 
 
 
 
 
 
Enter your cell lines of interest*
 
 
 
 
  
 
 
I have read and agree to the Promega Guidelines for Processing Personal Information (see link below).*
 
 
 
 
I agree to receive e-mails about events, promotions, surveys, products and technologies.*
 
 
 
 
 
 
 
Overview
Protocols
Specifications
Resources
Related Products

HiBiT Knock-In Cell Lines for RAS Pathway Targets

CRISPR-engineered HiBiT Knock-in Cell Lines offer a powerful tool to study the abundance and degradation of endogenous proteins involved in critical signaling pathways, such as the RAS-RAF-MEK-ERK cascade. This pathway begins with the activation of RAS, a family of small GTPases, which includes KRAS, HRAS and NRAS. Active, GTP-bound RAS activates the RAF family of serine/threonine kinases (c-Raf, B-Raf, A-Raf). This activation sequence leads to the phosphorylation of MEK and ultimately ERK, which are essential for controlling various cellular processes.


An overview of the RAS-RAF-MEK-ERK pathway.

An overview of the RAS-RAF-MEK-ERK pathway.

HiBiT is a small, 11-amino-acid epitope tag that enables precise measurement of protein expression through bioluminescent signal when bound to its complementation partner, LgBiT. The bound complex exhibits high luciferase activity, producing a bright luminescent signal in the presence of added substrate. The small size of the HiBiT tag makes it ideal for endogenous tagging using CRISPR/Cas9 editing.

When inserted into key proteins within this pathway using CRISPR technology, the HiBiT tag enables precise monitoring of protein dynamics in real-time. Upon binding with LgBiT, the HiBiT tag generates a luminescent signal, which decreases as the tagged protein undergoes degradation. This method allows researchers to quantitatively assess protein degradation rates, Dmax and DC50 values, making it a powerful tool for studying protein stability and for high-throughput screening of compounds that influence the RAS-RAF-MEK-ERK signaling pathway.

A.

Scatter plots of live-cell luminescence of HiBiT-KRasG12C with an LC-2 inhibitor.

B.

Scatter plots of live-cell luminescence of HiBiT-KRasG12C with an MRTX849 inhibitor.

Live-cell-degradation kinetics of endogenous HiBiT-KRasG12C following PROTAC treatment. Panel A. HiBiT was inserted via CRISPR/Cas9 at the N-terminal endogenous KRasG12C loci in the MIA-PaCa2 cell line. Following LgBiT expression, dose-response kinetic degradation experiments were performed using the VHL-based KRasG12C PROTAC, LC-2, in CO2-independent medium containing Nano-Glo® Endurazine™ Substrate. Fractional RLU is plotted relative to the DMSO control. Panel B. Similar live-cell luminescent studies of HiBiT-KRasG12C in MIA-Paca2 cells using the parent inhibitor, MRTX849, which does not show loss of KRasG12C over the same dose-response treatments.

 

Interested in our other CRISPR knock-in cell lines? View our full library of ready-to-use cells.

Protocols

No protocols available

Specifications

Catalog Number: